[go: up one dir, main page]

ES542430A0 - Un procedimiento para la preparacion de una composicion antiacida de alginato de magnesio. - Google Patents

Un procedimiento para la preparacion de una composicion antiacida de alginato de magnesio.

Info

Publication number
ES542430A0
ES542430A0 ES542430A ES542430A ES542430A0 ES 542430 A0 ES542430 A0 ES 542430A0 ES 542430 A ES542430 A ES 542430A ES 542430 A ES542430 A ES 542430A ES 542430 A0 ES542430 A0 ES 542430A0
Authority
ES
Spain
Prior art keywords
anticid
procedure
preparation
composition
magnesium alginate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES542430A
Other languages
English (en)
Other versions
ES8706029A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rorer International Overseas Inc
Original Assignee
Rorer International Overseas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rorer International Overseas Inc filed Critical Rorer International Overseas Inc
Publication of ES8706029A1 publication Critical patent/ES8706029A1/es
Publication of ES542430A0 publication Critical patent/ES542430A0/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES542430A 1984-04-19 1985-04-19 Un procedimiento para la preparacion de una composicion antiacida de alginato de magnesio. Expired ES8706029A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60179684A 1984-04-19 1984-04-19

Publications (2)

Publication Number Publication Date
ES8706029A1 ES8706029A1 (es) 1987-06-01
ES542430A0 true ES542430A0 (es) 1987-06-01

Family

ID=24408805

Family Applications (1)

Application Number Title Priority Date Filing Date
ES542430A Expired ES8706029A1 (es) 1984-04-19 1985-04-19 Un procedimiento para la preparacion de una composicion antiacida de alginato de magnesio.

Country Status (11)

Country Link
EP (1) EP0179858B1 (es)
JP (1) JPH0764737B2 (es)
KR (1) KR850007561A (es)
CN (1) CN85104754A (es)
AT (1) ATE77750T1 (es)
AU (1) AU578690B2 (es)
CA (1) CA1259916A (es)
DE (1) DE3586281T2 (es)
ES (1) ES8706029A1 (es)
FR (1) FR2563108B1 (es)
WO (1) WO1985004806A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4744986A (en) * 1986-03-07 1988-05-17 Rorer Pharmaceutical Corporation Process for the preparation of a viscosity-stable antacid composition
DE3612086A1 (de) * 1986-04-10 1987-10-15 Bayer Ag Konservierte antacida-zubereitungen
DK179687D0 (da) * 1987-04-08 1987-04-08 Farma Food As Praeparat
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
US5360793A (en) * 1993-05-24 1994-11-01 Sterling Winthrop Inc. Rafting antacid formulation
GB9504599D0 (en) * 1995-03-03 1995-04-26 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
DE69736955T2 (de) * 1996-10-04 2007-07-12 Merck & Co., Inc. Verfahren und zusammensetzungen zur vorbeugung und behandlung von sodbrennen
BR9809310A (pt) 1997-04-30 2000-07-04 Reckitt & Colmann Prod Ltd Composição lìquida aquosa derramável, composições farmacêuticas e processos para o tratamento da esofagite de refluxo, gastrite, dispepsia ou ulceração péptica, e para formar um revestimento protetor sobre o tecido da mucosa gastrintestinal, composição farmacêutica em forma de dosagem unitária sólida.
WO2003043641A1 (en) * 2001-11-19 2003-05-30 Nobel Ilaç Sanayii Ve Ticaret A.S. New pharmaceutical combinations prepared with alginates and biphosphonates in order to prevent gastroesophageal reflux during use of oral biphoshonates
WO2005018613A1 (de) * 2003-08-26 2005-03-03 Mandapro Ag Pellets für die orale applikation von pharmazeutischen wirkstoffen
DE102006037298A1 (de) 2006-08-08 2008-02-14 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung, insbesondere Antazidum
IT1406155B1 (it) * 2011-02-22 2014-02-14 Rossi Composizioni di alginato di magnesio e derivati come adiuvanti nel trattamento del reflusso gastrico
LT2806880T (lt) 2012-01-27 2017-08-25 Institute Of Bioorganic Chemistry Farmacinė kompozicija, kaip substancija antacidiniam vaistui nuo refliukso
CN104688765A (zh) * 2013-12-04 2015-06-10 博晖(大连)实业有限公司 一种由海藻酸盐组合的组方胃药
IT202100000059A1 (it) * 2021-01-04 2022-07-04 Nyuma Pharma Srl Nuove composizioni di sucralfato in alginato e loro utilizzo in terapia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1363399A (en) * 1972-04-13 1974-08-14 Rotta Research Lab Method of preparing an antacid pharmaceutical product
GB1524740A (en) * 1976-11-09 1978-09-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions for use in the suppression of gastric reflux
GB1598375A (en) * 1978-02-17 1981-09-16 Anphar Sa Aluminium magnesium carbonate

Also Published As

Publication number Publication date
DE3586281D1 (de) 1992-08-06
CA1259916A (en) 1989-09-26
AU578690B2 (en) 1988-11-03
FR2563108A1 (fr) 1985-10-25
DE3586281T2 (de) 1992-12-10
KR850007561A (ko) 1985-12-07
EP0179858A4 (en) 1986-09-15
CN85104754A (zh) 1986-12-10
WO1985004806A1 (en) 1985-11-07
AU4233685A (en) 1985-11-15
EP0179858B1 (en) 1992-07-01
EP0179858A1 (en) 1986-05-07
ATE77750T1 (de) 1992-07-15
JPH0764737B2 (ja) 1995-07-12
ES8706029A1 (es) 1987-06-01
FR2563108B1 (fr) 1987-09-04
JPS61501916A (ja) 1986-09-04

Similar Documents

Publication Publication Date Title
ES542430A0 (es) Un procedimiento para la preparacion de una composicion antiacida de alginato de magnesio.
IT9048558A0 (it) Composizione adesiva per protesi dentarie e procedimento per la sua preparazione.
BR9006965A (pt) Agentes de higiene dental e oral
IT8548445A0 (it) Composizione farmaceutica e lento rilascio e metodo per la sua preparazione
IT1246341B (it) Perfezionata composizione adesiva per protesi dentarie e procedimento per la sua preparazione.
DE3872493D1 (de) Verbundmaterial sowie dazu verwendetes fuellmaterial.
IT8922164A0 (it) Composizione farmaceutica e procedimento per la sua preparazione
IT1178324B (it) Procedimento e composizione per prevenire la placca dentaria e la gengivite
IT1216139B (it) Composizione dietetica eprocedimento per la sua preparazione.
NO893892D0 (no) Antimikrobiologisk sammensetning og fremgangsmaate for anvendelse.
FR2611205B1 (fr) Dipeptides, procede de preparation et utilisation dans le dosage de proteases
NZ223293A (en) Beta-alkyl melatonins and pharmaceutical compositions
IT8622122A0 (it) Adesivo per protesi dentarie osimilari e procedimento per la sua fabbricazione.
EP0390849A4 (en) Methyl cellulose pharmaceutical composition
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
IT1217352B (it) Palizzata in calcestruzzo nonche'procedimento e dispositivo per laproduzione della stessa.
EP0371733A3 (en) Dopamine-beta-hydroxylase inhibitors
IT8519986A0 (it) Dispositivo e procedimento per lapreparazione di pre-calchi per protesi dentarie.
GR3005231T3 (es)
IT1217789B (it) Composizione farmaceutica cue si accumula nella pelle e procedimento per la sua preparazione
ES540196A0 (es) Procedimiento para la obtencion de una composicion blanquea-dora y azuladora para el tratamiento de tejidos
FI874823A (fi) Farmaceutisk komposition foer anvaendning mot hypertension och kongestiv hjaertinsufficiens.
NO884696D0 (no) Komposittmateriale og fremgangsmaate for dets fremstilling.
MX11486A (es) Procedimiento para la preparacion de una composicion farmaceutica y composicion obtenida.
IT1216894B (it) Composizione farmaceutica eprocedimento per la sua preparazione.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20070319